- Brands
- Offerings
- Diagnostic Panels
- Events
- Knowledge Center
- Diagnostics
Data housed in multiple, disparate laboratory IT systems make it difficult to capture the information you need to drive efficiency. This can result in fragmented processes. What if you could harmonize the data from virtually any LIS, analyzer or automation system across your entire institution? Watch the video to see how.
With AlinIQ AMS, the analyzer management system from Abbott, you can standardize IT and workflow functionality across your entire laboratory system. AlinIQ AMS is an open, scalable solution that can connect virtually any analyzer or automation system to the LIS to better manage the flow of data throughout the entire workflow process.
With five categories of capabilities – combined with expert advisors – AlinIQ AMS enhances your operational efficiency and quality beyond your laboratory information system.
Discover more about AlinIQ AMS and how it can help ehnance your laboratory operations.
Learn more about the five categories of capabilities and how they can help enhance your operational efficiency and quality beyond your laboratory information system.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.